A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma (ReACT)
 
Sponsors and Collaborators
Celldex Therapeutics
 
Contact
Celldex Therapeutics
 
ClinicalTrials.gov Identifier